Wang Li, Wang Qing, Tian Xiaochao, Shi Xinli
Hebei Key Laboratory of Integrative Medicine on Liver-Kidney Patterns, Hebei University of Chinese Medicine, Shijiazhuang; Research Center of Combine Traditional Chinese and Western Medicine, Affiliated Traditional Medicine Hospital, Sichuan Medical University, Luzhou, China.
Department of Medical Affair, Chengdu Military General Hospital, Chengdu, Sichuan, China.
J Cancer Res Ther. 2018;14(Supplement):S1-S6. doi: 10.4103/0973-1482.204841.
Side effects associated with conventional anticancer therapies have prompted the new idea of solid tumor treatment strategy. One of them is using bacteria explored as potential antitumor agents over more than one century. Notably, the ideal therapy is a specifical target to tumors with limited toxicity. Here, we take "Clostridium novyi" for the search keyword in the PubMed from 2000 to 2015 and describe that C. novyi-NT spores act as "Trojan horse" for bacteriolytic therapy. This therapy is based on the fact that the live and attenuated obligate anaerobic bacteria are capable of binary fission selectively in anoxic areas of solid tumors and direct tumoricidal effects. Our succinct review mainly concentrates on the potential mechanisms of combination bacteriolytic therapy, an effective and safe tumor therapy with the help of C. novyi-NT. Importantly, C. novyi-NT spores were shown to induce solid tumor regression and exhibit the property to initiate an immune response. Therefore, C. novyi-NT spores should be an effective and safe tumor therapy.
传统抗癌疗法的副作用催生了实体瘤治疗策略的新想法。其中之一是利用细菌作为潜在的抗肿瘤药物,这一探索已历经一个多世纪。值得注意的是,理想的疗法是对肿瘤有特异性靶向作用且毒性有限。在此,我们以“产气荚膜梭菌”为关键词在2000年至2015年的PubMed数据库中进行检索,并描述了产气荚膜梭菌NT株芽孢在溶菌疗法中充当“特洛伊木马”的作用。这种疗法基于这样一个事实,即活的减毒专性厌氧菌能够在实体瘤的缺氧区域选择性地进行二分裂并产生直接的杀肿瘤作用。我们的简要综述主要聚焦于联合溶菌疗法的潜在机制,这是一种借助产气荚膜梭菌NT株实现的有效且安全的肿瘤治疗方法。重要的是,产气荚膜梭菌NT株芽孢已被证明可诱导实体瘤消退并具有引发免疫反应的特性。因此,产气荚膜梭菌NT株芽孢应是一种有效且安全的肿瘤治疗方法。